Cathy S. Wang

1.1k total citations
32 papers, 802 citations indexed

About

Cathy S. Wang is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Cathy S. Wang has authored 32 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 15 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Cathy S. Wang's work include Multiple Myeloma Research and Treatments (20 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Glycosylation and Glycoproteins Research (5 papers). Cathy S. Wang is often cited by papers focused on Multiple Myeloma Research and Treatments (20 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Glycosylation and Glycoproteins Research (5 papers). Cathy S. Wang collaborates with scholars based in United States, Switzerland and Germany. Cathy S. Wang's co-authors include James R. Berenson, Eric Sanchez, Mingjie Li, Haiming Chen, Regina A. Swift, George Tang, Benjamin Bonavida, Suzie Vardanyan, Nika M Harutyunyan and Tanya M. Spektor and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Cathy S. Wang

32 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cathy S. Wang United States 12 451 449 328 240 190 32 802
Kimberly H. Harrington United States 11 492 1.1× 307 0.7× 343 1.0× 254 1.1× 206 1.1× 17 807
Homer Adams United States 10 401 0.9× 401 0.9× 249 0.8× 195 0.8× 237 1.2× 25 713
Kenneth Wen United States 16 787 1.7× 740 1.6× 570 1.7× 209 0.9× 427 2.2× 52 1.3k
Hidekazu Segawa Japan 15 458 1.0× 233 0.5× 317 1.0× 180 0.8× 106 0.6× 20 985
Siobhan Glavey United States 10 315 0.7× 448 1.0× 499 1.5× 61 0.3× 206 1.1× 19 853
Dirk Zboralski United States 13 503 1.1× 135 0.3× 332 1.0× 149 0.6× 218 1.1× 22 937
Michael R. Burgess United States 16 336 0.7× 586 1.3× 370 1.1× 104 0.4× 206 1.1× 27 986
FO Smith United States 9 281 0.6× 596 1.3× 426 1.3× 189 0.8× 173 0.9× 15 1.1k
Lijie Xing China 14 393 0.9× 364 0.8× 336 1.0× 136 0.6× 176 0.9× 49 669
L. Claire Tsao United States 9 467 1.0× 527 1.2× 399 1.2× 137 0.6× 200 1.1× 12 812

Countries citing papers authored by Cathy S. Wang

Since Specialization
Citations

This map shows the geographic impact of Cathy S. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy S. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy S. Wang more than expected).

Fields of papers citing papers by Cathy S. Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy S. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy S. Wang. The network helps show where Cathy S. Wang may publish in the future.

Co-authorship network of co-authors of Cathy S. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Cathy S. Wang. A scholar is included among the top collaborators of Cathy S. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathy S. Wang. Cathy S. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freedman, Benjamin R., et al.. (2022). Aging and matrix viscoelasticity affect multiscale tendon properties and tendon derived cell behavior. Acta Biomaterialia. 143. 63–71. 22 indexed citations
2.
Amini, Ava P., Jesse D. Kirkpatrick, Cathy S. Wang, et al.. (2022). Multiscale profiling of protease activity in cancer. Nature Communications. 13(1). 5745–5745. 32 indexed citations
3.
Li, Mingjie, Nicole Ng, Sean Bujarski, et al.. (2020). Ruxolitinib reverses checkpoint inhibition by reducing programmed cell death ligand‐1 (PD‐L1) expression and increases anti‐tumour effects of T cells in multiple myeloma. British Journal of Haematology. 192(3). 568–576. 21 indexed citations
4.
Chang, Tiffany, Sean Bujarski, Camilia Soof, et al.. (2019). Normalization of Serum B-Cell Maturation Antigen Levels from Treatment Predicts Progression Free and Overall Survival in Multiple Myeloma Patients. Blood. 134(Supplement_1). 4393–4393. 3 indexed citations
5.
Sanchez, Eric, Mingjie Li, Camilia Soof, et al.. (2018). The clinical significance of B-cell maturation antigen as a therapeutic target and biomarker. Expert Review of Molecular Diagnostics. 18(4). 319–329. 24 indexed citations
6.
Bujarski, Sean, Camilia Soof, Haiming Chen, et al.. (2018). Serum b-cell maturation antigen levels to predict progression free survival and responses among relapsed or refractory multiple myeloma patients treated on the phase I IRUX trial.. Journal of Clinical Oncology. 36(15_suppl). e24313–e24313. 7 indexed citations
7.
Chen, Haiming, Mingjie Li, Eric Sanchez, et al.. (2017). Combined TRAF6 Targeting and Proteasome Blockade Has Anti-myeloma and Anti-Bone Resorptive Effects. Molecular Cancer Research. 15(5). 598–609. 18 indexed citations
8.
Li, Mingjie, Eric Sanchez, Camilia Soof, et al.. (2017). Serum Bcma May Interfere with Anti-Bcma-CAR-Transduced T Cells or Other Anti-Bcma Antibody-Based Immunotherapy in Multiple Myeloma. Blood. 130. 4413–4413. 6 indexed citations
9.
Bujarski, Sean, Kyle A. Udd, Camilia Soof, et al.. (2017). Changes in Serum B-Cell Maturation Antigen Levels Rapidly Indicate Changes in Clinical Status Among Multiple Myeloma Patients Undergoing New Treatments. Blood. 130. 4371–4371. 1 indexed citations
10.
11.
Sanchez, Eric, Mingjie Li, Cathy S. Wang, et al.. (2017). Anti-angiogenic and anti-multiple myeloma effects of oprozomib (OPZ) alone and in combination with pomalidomide (Pom) and/or dexamethasone (Dex). Leukemia Research. 57. 45–54. 11 indexed citations
12.
Sanchez, Eric, Emily J. Smith, Mingjie Li, et al.. (2017). The Role of B-Cell Maturation Antigen in the Biology and Management of, and as a Potential Therapeutic Target in, Multiple Myeloma. Targeted Oncology. 13(1). 39–47. 35 indexed citations
13.
Li, Mingjie, Suzie Vardanyan, Nika M Harutyunyan, et al.. (2016). Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients. Haematologica. 102(4). 785–795. 140 indexed citations
14.
Sanchez, Eric, George Tang, Nika M Harutyunyan, et al.. (2016). Soluble B-Cell Maturation Antigen Mediates Tumor-Induced Immune Deficiency in Multiple Myeloma. Clinical Cancer Research. 22(13). 3383–3397. 87 indexed citations
15.
Sanchez, Eric, Mingjie Li, Cathy S. Wang, et al.. (2016). Effects of INCB052793, a Selective JAK1 Inhibitor, in Combination with Anti-Myeloma Agents on Human Multiple Myeloma (MM) In Vitro and In Vivo. Blood. 128(22). 3297–3297. 1 indexed citations
16.
Sanchez, Eric, Mingjie Li, Jennifer Li, et al.. (2012). Serum B‐cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival. British Journal of Haematology. 158(6). 727–738. 210 indexed citations
17.
Li, Mingjie, David A. Gutierrez, Cydney Nichols, et al.. (2011). TRAF6 Dominant Negative Peptides Block Intracellular Signaling Resulting in Anti-Myeloma and Anti-Bone Resorptive Effects in Multiple Myeloma. Blood. 118(21). 2919–2919. 1 indexed citations
18.
Chen, Haiming, Rui Hao, Eric Sanchez, et al.. (2009). Pterostilbene: A Novel Histone Deacetylase 1 Inhibitor (HDACi1) Demonstrating Efficacy in Multiple Myeloma.. Blood. 114(22). 3844–3844. 1 indexed citations
19.
Sanchez, Eric, Mingjie Li, Jeffrey A. Steinberg, et al.. (2009). Oral Dosing of the Novel Proteasome Inhibitor CEP-18770 Shows Marked Anti-Myeloma Effects in SCID-Hu Models of Multiple Myeloma.. Blood. 114(22). 1840–1840. 8 indexed citations
20.
Chen, Haiming, Melinda S. Gordon, Richard A. Campbell, et al.. (2007). Pleiotrophin is highly expressed by myeloma cells and promotes myeloma tumor growth. Blood. 110(1). 287–295. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kimberly H. Harrington Breakdown of academic impact, for papers by Homer Adams Breakdown of academic impact, for papers by Kenneth Wen Breakdown of academic impact, for papers by Hidekazu Segawa Breakdown of academic impact, for papers by Siobhan Glavey Breakdown of academic impact, for papers by Dirk Zboralski Breakdown of academic impact, for papers by Michael R. Burgess Breakdown of academic impact, for papers by FO Smith Breakdown of academic impact, for papers by Lijie Xing Breakdown of academic impact, for papers by L. Claire Tsao
Rankless by CCL
2026